Report: Vaccines market to grow by 2020

30 July 2015

The global vaccines market is expected to be worth $2.85 billion by the end of 2020, with North America being the largest market with more than 36% share, according to a new report from Mordor Intelligence.

The report, Global Therapeutic Vaccines Market – Growth, Trends & Forecasts (2015-2020), found that the market is expected to expand at a compound annual growth rate (CAGR) of 44.6% during the period. The market is dominated by five major players: French drug major Sanofi's (Euronext: SAN) vaccine unit Sanofi Pasteur, UK pharma major GlaxoSmithKline (LSE: GSK), US pharma giants Merck & Co (NYSE: MRK) and Pfizer (NYSE: PFE), and Swiss pharma major Novartis (NOVN: VX).

Drivers for growth

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK